Loading provider…
Loading provider…
Urology Physician in Lakeland, FL
NPI: 1245436518Primary Practice Location
LAKELAND REGIONAL MEDICAL CENTER
1324 Lakeland Hills Blvd, Lakeland, FL
Primary Employer
Lakeland Regional Health Systems, Inc.
mylrh.org
HQ Phone
Get MD Peter's Phone Numberphone_androidMobile
Get MD Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
NY State Medical License
NJ State Medical License
FL State Medical License
2017 - 2027
NJ State Medical License
2008 - 2019
GA State Medical License
2013 - 2017
PA State Medical License
2012 - 2014
NY State Medical License
2006 - 2008

American Board of Urology
Urology
SUNY Downstate Health Sciences University
downstate.edu
Medical School
Until 2005
UPMC Medical Education
Fellowship • Minimally Invasive Urologic Surgery
2012 - 2014
Rutgers Health/New Jersey Medical School
Residency • Urology
2007 - 2012
Rutgers Health
Internship • Transitional Year
2005 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 125 | 200 |
| 2 | 81001Manual urinalysis test with examination using microscope | 68 | 99 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 62 | 83 |
| 4 | 84153PSA (prostate specific antigen) measurement | 60 | 95 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 59 | 61 |
Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma.
Authors: Adam Sendor, Abraham Hakimi, Pheroze Tamboli, Wendy Rathmell, Toni Choueiri
Journal: PLoS One
Publication Date: 2014-12-26
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
Authors: Wendy Rathmell, Toni Choueiri
Publication Date: 2013-12-23
Challenges and Issues in Conducting Descriptive Decision-Making Studies in Pediatric Oncology: A Tale of Two Studies
Authors: Peter Hinds, MD
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, OTHER: Quality-of-Life Assessment, PROCEDURE: Nephrectomy, OTHER: Patient Observation